Evidence map›Paper›PMID 39896259›Full record

ArticlePatterns (New York, N.Y.)2025

PhosNetVis: A web-based tool for fast kinase-substrate enrichment analysis and interactive 2D/3D network visualizations of phosphoproteomics data.

Osho Rawal, Berk Turhan, Irene Font Peradejordi, Shreya Chandrasekar, Selim Kalayci, Sacha Gnjatic, Jeffrey Johnson, Mehdi Bouhaddou, Zeynep H Gümüş

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Osho RawalDepartment of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Berk TurhanDepartment of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Irene Font PeradejordiDepartment of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Shreya ChandrasekarDepartment of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Selim KalayciDepartment of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Sacha GnjaticMarc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Jeffrey JohnsonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Mehdi BouhaddouDepartment of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Zeynep H GümüşDepartment of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Funding

THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ramon E Parsons · 2015 to 2026
$35.4M
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy TrialsU24CA224319 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Sacha Gnjatic, Seunghee Kim-Schulze · 2017 to 2026
$21.5M
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patientsU01DK124165 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI COLOMBEL, JEAN-FREDERIC, FAITH, JEREMIAH JAMES · 2020 to 2024
$2.9M
PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trialsR33CA263705 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GUMUS, ZEYNEP HULYA · 2021 to 2021
$1.5M
Decoding Viral Control of Host Kinase Signaling to Design Combination TherapyK99AI163868 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOUHADDOU, MEHDI · 2022 to 2022
$125k
NCI NIH HHS P30 CA196521NCI NIH HHS R33 CA263705NCI NIH HHS U24 CA224319NIAID NIH HHS K99 AI163868NIDDK NIH HHS U01 DK124165
6 · The paper itself

Abstract

Protein phosphorylation involves the reversible modification of a protein (substrate) residue by another protein (kinase). Liquid chromatography-mass spectrometry studies are rapidly generating massive protein phosphorylation datasets across multiple conditions. Researchers then must infer kinases responsible for changes in phosphosites of each substrate. However, tools that infer kinase-substrate interactions (KSIs) are not optimized to interactively explore the resulting large and complex networks, significant phosphosites, and states. There is thus an unmet need for a tool that facilitates user-friendly analysis, interactive exploration, visualization, and communication of phosphoproteomics datasets. We present PhosNetVis, a web-based tool for researchers of all computational skill levels to easily infer, generate, and interactively explore KSI networks in 2D or 3D by streamlining phosphoproteomics data analysis steps within a single tool. PhostNetVis lowers barriers for researchers by rapidly generating high-quality visualizations to gain biological insights from their phosphoproteomics datasets. It is available at https://gumuslab.github.io/PhosNetVis/.

Indexed as

3D visualizationCPTACfast kinase-substrate enrichment analysisinteractive visualizationkinase-substrate interactionnetwork visualizationphosphoproteomicsphosphorylation

Identifiers

PMID39896259
PMCPMC11783894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.